Jeddah, Saudi Arabia

Nouf Saeed A Al-Abbas

This inventor holds 1 USPTO granted patent. Top assignee: King Abdulaziz University. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nouf Saeed A Al-Abbas. Retrieved from https://idiyas.com/inventor/nouf-saeed-a-al-abbas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nouf Saeed A Al-Abbas: Innovator in Cancer Treatment

Introduction

Nouf Saeed A Al-Abbas is a prominent inventor based in Jeddah, Saudi Arabia. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. His innovative work has the potential to impact the lives of many patients battling this disease.

Latest Patents

Al-Abbas holds a patent for a pharmaceutical composition aimed at treating cancer. This composition features an anticancer compound known as isopicrinine, which is isolated from a plant. The patent also includes a method for treating cancer using this pharmaceutical composition. Additionally, it outlines a method for extracting isopicrinine, showcasing his commitment to advancing cancer treatment options.

Career Highlights

Al-Abbas is affiliated with King Abdulaziz University, where he contributes to research and development in the pharmaceutical field. His work at the university allows him to collaborate with other experts and further his research endeavors.

Collaborations

Some of his notable coworkers include Jamal Sabir M Sabir and Abdullah Yousef Obaid. Their collaboration enhances the research environment and fosters innovation in their projects.

Conclusion

Nouf Saeed A Al-Abbas is a dedicated inventor whose work in cancer treatment exemplifies the importance of innovation in pharmaceuticals. His contributions are paving the way for new therapeutic options that could benefit countless individuals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…